Endpoints News· @endpts · X·· 3 小时前精选AI 评分58
AI 导读
罗氏在七周内完成第四笔中国交易，最新一笔与知名度不高的Defand合作，方向为分子胶降解剂。原文链接：https://endpoints.news/roche-does-fourth-china-deal-since-august-teaming-with-defand-on-degraders/
推荐理由
罗氏七周内第四次在华达成交易，读者可借此观察其在中国BD的节奏与分子胶降解剂布局。
正文
Roche has now done four China deals in seven weeks. Its latest is with little-known Defand on molecular glue degraders. https://endpoints.news/roche-does-fourth-china-deal-since-august-teaming-with-defand-on-degraders/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
来源：Endpoints News · x.com